WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹15 Cr | ₹-32 Cr | ₹-29 Cr | ₹-17 Cr | ₹-108 Cr |
What is the latest Cash Flow from Financing Activities ratio of WANBURY ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹15 Cr |
Mar2023 | ₹-32 Cr |
Mar2022 | ₹-29 Cr |
Mar2021 | ₹-17 Cr |
Mar2020 | ₹-108 Cr |
How is Cash Flow from Financing Activities of WANBURY Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹15 Cr | Positive | |
Mar2023 | ₹-32 Cr | Negative | |
Mar2022 | ₹-29 Cr | Negative | |
Mar2021 | ₹-17 Cr | Negative | |
Mar2020 | ₹-108 Cr | - |
Compare Cash Flow from Financing Activities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹862.6 Cr | -12.2% | -10% | 118.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,830.0 Cr | -2.2% | 1.7% | 41.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,644.0 Cr | -4.6% | -1.6% | 45.8% | Stock Analytics | |
CIPLA | ₹120,742.0 Cr | -2.8% | 1.8% | 15.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,366.0 Cr | -0.2% | 9.2% | 15.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,766.9 Cr | -0.9% | -0.1% | 41.1% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -12.2% |
-10% |
118.3% |
SENSEX | -0.5% |
-4.4% |
9.5% |
You may also like the below Video Courses